PKOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. PKOH is trading pre-market at 22.23, below the 22.637 pivot with a bearish, worsening MACD histogram and no Intellectia buy signals. Options positioning is skewed bullish (very low put/call OI), but there’s effectively no option volume confirming near-term conviction. With the latest quarter (2025/Q3) showing clear YoY deterioration in revenue, EPS, and margins, the risk/reward for an impatient buyer is unattractive at the current level.
Trend/Momentum: Mixed-to-soft. While the moving-average structure is bullish (SMA_5 > SMA_20 > SMA_200), momentum is weakening: MACD histogram is -0.116 and negatively expanding (bearish acceleration). RSI(6) at ~45.8 is neutral, not signaling an oversold bounce.
Price context & levels: Pre-market 22.23 is below the pivot (22.637), suggesting near-term pressure unless it reclaims that level. Key support sits at S1 21.556 (then S2 20.888). Resistance levels are R1 23.718 and R2 24.386.
Near-term setup: Without a clear momentum turn (MACD improving) or a reclaim of the pivot, the technicals do not favor an immediate buy for someone who wants quick confirmation.
Intellectia Proprietary Trading Signals
suggests market participants are positioned more for upside than downside.
Momentum deterioration: Bearish and expanding MACD histogram while price sits below pivot level—suggests downside risk toward 21.56 support.
Fundamental weakening (latest quarter 2025/Q3): Revenue, net income, EPS, and gross margin all declined YoY.
Lack of institutional/insider signal: Hedge funds and insiders are described as neutral with no significant recent trend.
No event-driven upside catalyst in the provided news beyond the dividend item.
Latest quarter: 2025/Q3. Growth/profitability trend: Weak. Revenue fell to 398.6M (-4.55% YoY). Net income fell to 5.3M (-45.92% YoY). EPS fell to 0.38 (-47.95% YoY). Gross margin declined to 16.71 (-3.47% YoY). Overall, profitability is compressing faster than revenue, which is a negative setup for near-term stock performance unless there’s a clear turnaround catalyst.
No analyst rating trend or price target change data was provided, so a meaningful summary of recent upgrades/downgrades or Wall Street pros/cons cannot be confirmed from this dataset.
Influential/political trading check: No recent congress trading data available in the last 90 days; no politician/influential buying/selling information was provided.
